­
­
­
­

Inventi Impact: Cardiology & Haematology

Articles

  • Inventi:hch/23929/17
    Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients\nwithout Autologous Hematopoietic Stem Cell Transplantation
    01-Jan-1970 Research 2017 : October - December
    Liping Fan, Danhui Fu, Jinping Zhang, Haobo Huang, Qingqing Wang, Yamei Ye, Qianling Xie

    The aim of this study was to evaluate whether blood transfusions affect overall survival (OS) and progression-free survival (PFS)\nin newly diagnosed multiple myeloma (MM) patients without hematopoietic stem cell transplantation. A total of 181 patients were\nenrolled and divided into two groups: 68 patients in the transfused group and 113 patients in the nontransfused group. Statistical\nanalyses showed that there were significant differences in ECOG scoring, Ig isotype, platelet (Plt) counts, hemoglobin (Hb) level,\nserum creatinine (Scr) level, and

    How to Cite this Article
    CC Compliant Citation: Liping Fan, Danhui Fu, Jinping Zhang, et\nal., â??Prognostic Significance of Blood Transfusion in Newly\nDiagnosed Multiple Myeloma Patients without Autologous\nHematopoietic Stem Cell Transplantation,â? BioMed Research\nInternational, vol. 2017, Article ID 5462087, 6 pages, 2017.\ndoi:10.1155/2017/5462087, http://creativecommons.org/\nlicenses/by/4.0/.
    Download Full Text